Satter Management Co., L.P. Akebia Therapeutics, Inc. Transaction History
Satter Management Co., L.P.
- $57.4 Million
- Q3 2024
A detailed history of Satter Management Co., L.P. transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Satter Management Co., L.P. holds 5,747,906 shares of AKBA stock, worth $10.6 Million. This represents 13.23% of its overall portfolio holdings.
Number of Shares
5,747,906
Previous 5,747,906
-0.0%
Holding current value
$10.6 Million
Previous $5.86 Million
29.43%
% of portfolio
13.23%
Previous 11.5%
Shares
5 transactions
Others Institutions Holding AKBA
# of Institutions
120Shares Held
54.8MCall Options Held
291KPut Options Held
179K-
Black Rock Inc. New York, NY11.6MShares$21.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$18.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.75MShares$8.75 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.72MShares$6.84 Million0.01% of portfolio
-
State Street Corp Boston, MA3.43MShares$6.31 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $338M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...